Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cut In Australia Drug Support Leads Seniors To Trim Use

This article was originally published in PharmAsia News

Executive Summary

A recent move by the Australian government to cut its share of the cost of drugs for retirees has led many to cut back on their medicines by an average of 11 percent. Some have stopped taking life-saving drugs, according to a study of the impact of the government move. The report says the biggest decline in drug use among the group was among those with asthma, blood-clot risks, osteoporosis and ulcers. A federal funding cut had a similar impact three years ago on the use of anti-cholesterol drugs. The price of some drugs for seniors increased by 90 percent after the federal-support reduction. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066964

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel